Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
METTL14 promotes intimal hyperplasia through m6A-mediated control of vascular smooth muscle dedifferentiation genes
Grace Chensee, Bob S.L. Lee, Immanuel D. Green, Jessica Tieng, Renhua Song, Natalia Pinello, Quintin Lee, Majid Mehravar, David A. Robinson, Mian Wang, Mary M. Kavurma, Jun Yu, Justin J.L. Wong, Renjing Liu
Grace Chensee, Bob S.L. Lee, Immanuel D. Green, Jessica Tieng, Renhua Song, Natalia Pinello, Quintin Lee, Majid Mehravar, David A. Robinson, Mian Wang, Mary M. Kavurma, Jun Yu, Justin J.L. Wong, Renjing Liu
View: Text | PDF
Research Article Therapeutics Vascular biology

METTL14 promotes intimal hyperplasia through m6A-mediated control of vascular smooth muscle dedifferentiation genes

  • Text
  • PDF
Abstract

Vascular smooth muscle cells (VSMCs) possess significant phenotypic plasticity, shifting between a contractile phenotype and a synthetic state for vascular repair/remodeling. Dysregulated VSMC transformation, marked by excessive proliferation and migration, primarily drives intimal hyperplasia. N6-methyladenosine (m6A), the most prevalent RNA modification in eukaryotes, plays a critical role in gene expression regulation; however, its impact on VSMC plasticity is not fully understood. We investigated the changes in m6A modification and its regulatory factors during VSMC phenotypic shifts and their influence on intimal hyperplasia. We demonstrate that METTL14, crucial for m6A deposition, significantly promoted VSMC dedifferentiation. METTL14 expression, initially negligible, was elevated in synthetic VSMC cultures, postinjury neointimal VSMCs, and human restenotic arteries. Reducing Mettl14 levels in mouse primary VSMCs decreased prosynthetic genes, suppressing their proliferation and migration. m6A-RIP-seq profiling showed key VSMC gene networks undergo altered m6A regulation in Mettl14-deficient cells. Mettl14 enhanced Klf4 and Serpine1 expression through increased m6A deposition. Local Mettl14 knockdown significantly curbed neointimal formation after arterial injury, and reducing Mettl14 in hyperplastic arteries halted further neointimal development. We show that Mettl14 is a pivotal regulator of VSMC dedifferentiation, influencing Klf4- and Serpine1-mediated phenotypic conversion. Inhibiting METTL14 is a viable strategy for preventing restenosis and halting restenotic occlusions.

Authors

Grace Chensee, Bob S.L. Lee, Immanuel D. Green, Jessica Tieng, Renhua Song, Natalia Pinello, Quintin Lee, Majid Mehravar, David A. Robinson, Mian Wang, Mary M. Kavurma, Jun Yu, Justin J.L. Wong, Renjing Liu

×

Figure 5

Knockdown of Mettl14 significantly reduced neointima formation in a murine femoral artery wire injury model.

Options: View larger image (or click on image) Download as PowerPoint
Knockdown of Mettl14 significantly reduced neointima formation in a muri...
(A) Representative Western blots and quantification of Mettl14, Klf4, and Serpine1 expression in shCtrl- or shMettl14-2–transduced VSMCs 48 hours after infection. n = 3 independent repeats. (B) Representative EVG-stained cross sections of femoral arteries transduced with shCtrl or shMettl14-2 viruses 3 weeks after wire injury. Scale bars: 100 μm. (C) Quantification of neointimal ratio in B. n = 6 biologically independent samples. (D–G) Representative Mettl14, Klf4, Acta2, and Serpine1 immunofluorescent staining of murine femoral arteries 21 days after wire injury. Mettl14, purple; Klf4, red; Acta2, orange; Serpine1, white; elastin autofluorescence, green; DAPI, blue. Scale bars: 50 μm. Quantification of cell number or stained area in D–G is shown on the right. n = 5–8 biologically independent samples. MFI, mean fluorescence intensity. (H) Representative immunofluorescence images of murine femoral arteries 21 days after wire injury stained for p-Stat1 (Tyr701). p-Stat1, yellow; elastin autofluorescence, green; DAPI, blue. Scale bars: 50 μm. n = 5 biologically independent samples. (I) Representative Western blot of p-Stat1 and Stat1 expression and their quantification in shCtrl- or shMettl14-2–transduced VSMCs. n = 3 independent repeats. *P < 0.05; **P < 0.01; ****P < 0.001 by multiple unpaired, 2-tailed Student’s t test (A), 1-way ANOVA with Tukey’s multiple-comparison test (C and D–G), or unpaired, 2-tailed Student’s t test (I). Data are presented as mean ± SD.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts